Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Weitere Synonyme anzeigen
Wählen Sie die gewünschte Spezies
Our studies define a mechanism for BCL11A in regulation of hematopoietic stem cell function
Bcl11a enhancer-deleted mice, Bcl11a(Deltaenh), phenocopy the BCL11A-null state with respect to alterations of globin expression.
data identify Ctip1 as a critical control over sensory cortex development
Bcl11a haploinsufficiency in mice causes impaired cognition, abnormal social behavior, and microcephaly in accordance with the human phenotype
deletion of Bcl11a alters the regulation of hematopoietic stem cell quiescence, self-renewal, and fate choice
This study showed that the expression of Sema3c is increased in migrating Bcl11a-deficient neurons and that Bcl11a is a direct negative regulator of Sema3c transcription
The results of this study support a role for CTIP1 on the specification of the Subcerebral Projection Neurons in layer 5 through the repression of TBR1 and the promotion of CTIP2 expression.
Data indicate that Myb and BCL11A cooperate with DNMT1 to achieve developmental repression of embryonic and fetal beta-like human transgenic globin genes in the adult erythroid environment.
BCL11A is an essential, lineage-specific factor that regulates plasmacytoid dendritic cell development, supporting a model wherein differentiation into pDCs represents a primed "default" pathway for common dendritic cell progenitors.
Bcl11a controls Flt3 expression in early hematopoietic progenitors and is required for pDC development in vivo.
Immunohistochemical staining of mouse brain showed strong expression of BCL11A in the cortical regions and also in the pyramidal cell layers in the CA1 and CA3 regions of the hippocampus.
data support an important role for the KLF1-BCL11A axis in erythroid maturation and developmental regulation of globin expression
Overexpression of Bcl2 and Mdm2, or p53 deficiency, rescues both lethality and proliferative defects in Bcl11a-deficient early B cells.
BCL11A is required for silencing of gamma-globin expression in adult animals yet dispensable for red cell production; inactivation of BCL11A in sickle cell disease (SCD) transgenic mice corrects defects associated with SCD through HbF induction
Bcl11a is essential for postnatal development and normal lymphopoiesis.
CTIP1 and CTIP2 have roles in the development and function of both the central nervous and immune systems
Bcl11a is a SUMOylated protein and recruits SUMO-conjugation enzymes in its nuclear body.
deregulated Bcl11a cooperates with Nf1 in leukemogenesis
BCL11A is a critical mediator of species-divergent globin switching
Gene expression profiling reveals BCL11A-dependent regulation of multiple genes involved in insulin exocytosis.
BCL11A interacts with histone methyltransferase (PRC2) and histone deacetylase (NuRD and SIN3A) complexes through their common subunit, RBBP4/7.
BCL11A is integral to lung squamous cell carcinoma pathology and highlights the disruption of the BCL11A-SOX2 transcriptional programme as a novel candidate for drug development.
High BCL11A and MDR1 expression was associated with a poor response to chemotherapy.
miR-146a is a potential tumor suppressor gene in human neuroblastoma via directly targeting BCL11A
By perturbing BCL11A-DNMT1 interaction, miR-137 impairs cancer stemness and suppresses tumor development in Triple negative breast cancer.
APOL1, alpha-thalassemia, and BCL11A variants as a genetic risk profile for progression of chronic kidney disease in sickle cell anemia
the coding mRNA sequence of BCL11A can be targeted by miR-210.
BCL11A frameshift mutation associated with dyspraxia and hypotonia affecting the fine, gross, oral, and speech motor systems
IGF2BP1 mediates posttranscriptional loss of BCL11A in cultured human adult erythroblasts
The expression levels of Bcl11a and Mdm2, Pten in B-ALL patients with CR were decreased significantly when compared with the healthy control (P < 0.05).
Studied association of BCL11A single nucleotide polymorphisms(snps) and HBS1L-MYB Intergenic snps with Hereditary Persistence of Fetal Hemoglobin (HPFH) in a cohort of sickle cell patients.
both BCL11A and HMIP-2 were associated with increased endogenous levels of HbF. Interestingly, we also found that BCL11A was associated with higher induction of HbF with HU.
High BCL11A expression level was correlated with lower complete remission rate and shorter overall survival in adult acute myeloid leukemia patients.
Identification of novel mutations in the HbF repressor gene BCL11A in patients with autism and intelligence disabilities.
Ubiquitous knockdown of BCL11A in hematopoietic stem and progenitor cells impairs hematopoietic reconstitution after transplantation.
BCL11A rs11886868 and rs4671393 genotype variations and correspondingly high BCL11A plasma levels are related to laryngeal squamous cell carcinoma, besides, differences in plasma levels and genotype distribution may be related to lymph node metastasis status and the stage of laryngeal squamous cell carcinoma.
BCL11A may operate in transformation of CML from chronic to acute phase in some persons
The BCL11A gene was found to be potentially targeted by 12 MicroRNAs that were up-regulated in Hereditary persistence of fetal hemoglobin deletion type-2 (HPFH-2) or in Sicilian deltabeta-thalassemia. A down-regulation of BCL11A gene expression in HPFH-2 was verified by quantitative polymerase chain reaction.
The BCL11A protein is highly expressed in breast cancer and knock-down of BCL11A promotes the apoptosis of MDA-MB-231 cells.
This gene encodes a C2H2 type zinc-finger protein by its similarity to the mouse Bcl11a/Evi9 protein. The corresponding mouse gene is a common site of retroviral integration in myeloid leukemia, and may function as a leukemia disease gene, in part, through its interaction with BCL6. During hematopoietic cell differentiation, this gene is down-regulated. It is possibly involved in lymphoma pathogenesis since translocations associated with B-cell malignancies also deregulates its expression. Multiple transcript variants encoding several different isoforms have been found for this gene.
B-cell CLL/lymphoma 11A (zinc finger protein)
, B-cell lymphoma/leukemia 11A
, COUP-TF interacting protein 1
, COUP-TF-interacting protein 1
, ecotropic viral integration site 9 protein
, myeloid leukemia
, B-cell CLL/lymphoma 11A (zinc finger protein) isoform 2
, BCL11A B-cell CLL/lymphoma 11A (zinc finger protein) isoform 1
, C2H2-type zinc finger protein
, ecotropic viral integration site 9 homolog
, ecotropic viral integration site 9 protein homolog
, zinc finger protein 856
, B-cell CLL/lymphoma 11A